Movement Alert|Planet Labs Pbc Falls 5.44% in Regular Trading, Q3 Revenue Guidance Significantly Below Expectations Continues to Weigh on Stock

Market Focus
Sep 08

On September 8, Planet Labs Pbc fell 5.44% in regular trading, trading at $17.485/share, with turnover of $62.07 million, extending the post-earnings pullback that began after the company released its fiscal Q2 results.

On the news front, Planet Labs previously reported fiscal 2027 Q2 revenue of $116.1 million, up 58.2% year-over-year, significantly beating the consensus estimate of $104.5 million. However, adjusted EPS came in at a loss of $0.03, slightly missing the expected loss of $0.02. More critically, the company guided Q3 revenue to $101-$105 million, well below the analyst consensus of $114.0 million, representing a shortfall of roughly 8-11%. Full-year fiscal 2027 revenue guidance of $430-$441 million was largely in line with the $435.8 million estimate.

While positive developments — including a European defense contract, New Street upgrading the stock to Neutral with a $22 price target, and data center monitoring expansion plans — initially fueled a post-earnings rebound of over 9% in pre-market trading, the significant Q3 guidance gap has since erased those gains, with the stock falling more than two dollars from its post-earnings high as market confidence remains pressured.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10